1. Home
  2. CETY vs KPRX Comparison

CETY vs KPRX Comparison

Compare CETY & KPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Clean Energy Technologies Inc.

CETY

Clean Energy Technologies Inc.

N/A

Current Price

$0.91

Market Cap

11.6M

Sector

Utilities

ML Signal

N/A

Logo Kiora Pharmaceuticals Inc.

KPRX

Kiora Pharmaceuticals Inc.

N/A

Current Price

$1.57

Market Cap

10.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CETY
KPRX
Founded
1993
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6M
10.6M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
CETY
KPRX
Price
$0.91
$1.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.0K
★ 34.4K
Earning Date
11-18-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $957,633.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.46
$1.73
52 Week High
$2.98
$2.91

Technical Indicators

Market Signals
Indicator
CETY
KPRX
Relative Strength Index (RSI) 46.56 17.48
Support Level $0.88 N/A
Resistance Level $1.02 $2.19
Average True Range (ATR) 0.06 0.13
MACD -0.00 -0.07
Stochastic Oscillator 54.17 3.92

Price Performance

Historical Comparison
CETY
KPRX

About CETY Clean Energy Technologies Inc.

Clean Energy Technologies Inc develop renewable energy products and solutions and establish partnerships in renewable energy that make environmental and economic sense. Its segments are Waste Heat Recovery Solutions - It recycle wasted heat produced in manufacturing, waste to energy and power generation. Waste to Energy Solutions - It convert waste products created in manufacturing, agriculture, wastewater treatment plants and other industries to electricity, renewable natural gas hydrogen and bio char. Engineering, Consulting and Project Management Solutions - It provide power generation, waste to energy, and heat recovery, Procurement and Construction (EPC) services to municipal and industrial customers. It generates majority of revenue from United States followed by International.

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Share on Social Networks: